Archives
Review: Artificial intelligence in COVID-19 drug repurposing
22 Sep, 2020 | 09:36h | UTCArtificial intelligence in COVID-19 drug repurposing – The Lancet Digital Health
Clinical update: Hormonal contraception in women with hypertension
22 Sep, 2020 | 09:32h | UTCHormonal Contraception in Women With Hypertension – JAMA (free for a limited period)
Commentary on Twitter
https://twitter.com/JAMA_current/status/1308088618846691330
[ESMO2020 press release – Not published yet] Randomized trial: No benefit for post-operative radiotherapy in non-small-cell lung cancer
22 Sep, 2020 | 09:23h | UTCCommentary: Phase 3 Trial Results Do Not Support PORT in Resected Stage IIIAN2 NSCLC – Targeted Oncology
Concise review: Management of acute ischemic stroke
22 Sep, 2020 | 09:26h | UTCManagement of Acute Ischemic Stroke – Critical Care Medicine
A comprehensive update on aspirin management during noncardiac surgery
22 Sep, 2020 | 09:24h | UTCA Comprehensive Update on Aspirin Management During Noncardiac Surgery – Anesthesia & Analgesia
Increased patient safety-related incidents following the transition into daylight savings time
22 Sep, 2020 | 09:22h | UTC
Commentary on Twitter
As if it wasn’t bad enough we have to change the few remaining analog clocks twice a year due to daylight savings time (DST); DST change leads to about 19% more patient safety incidents in the following week attributed to human error. #PatientSafety https://t.co/YBFtgjgsLT
— David (@ResearchMohr) September 15, 2020
[Preprint] Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: An international collaborative meta-analysis of randomized trials
20 Sep, 2020 | 21:42h | UTC
Commentary on Twitter
This meta-analysis of 7,913 patients from 26 RCTs (16 unpublished) found no mortality benefit to #hydroxychloroquine or chloroquine in COVID19
Combined summary OR for all-cause mortality for HCQ 1.08, 95%CI 0.99-1.18
Confirms HCQ does not help, may harmhttps://t.co/4o9bXkOo5Q pic.twitter.com/QG1XMzN0da
— Ilan Schwartz is on🦋 (@GermHunterMD) September 19, 2020
Decreased influenza activity during the COVID-19 pandemic
20 Sep, 2020 | 21:39h | UTCCommentary: COVID-19 prevention might translate into – MedicalXpress
Severe COVID-19 infections—knowledge gained and remaining questions
20 Sep, 2020 | 21:43h | UTCSevere COVID-19 Infections—Knowledge Gained and Remaining Questions – JAMA Internal Medicine
Commentary on Twitter
Just out @JAMAInternalMed – our editorial on what we've learned about severe #Covid19 pneumonia so far and what challenges are still ahead. Honored and proud to have written this together with Carolyn Calfee and Dan Brodie. https://t.co/rmVjUWNyvM
— Lieuwe Bos – Acute Pulmonary Medicine (@Acute_Pulmo_Med) September 18, 2020
Transmission of SARS-CoV-2 during long flights
20 Sep, 2020 | 21:36h | UTCRelated Study: In-Flight Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 – CDC Emerging Infectious Diseases
Commentary: Coronavirus can spread on airline flights, two studies show – CNN
Systematic Review: Coronavirus infection in neonates
20 Sep, 2020 | 21:34h | UTCCoronavirus infection in neonates: a systematic review – ADC Fetal & Neonatal
Commentary on Twitter
#SARSCoV2 #review of 26 studies with 44 infected newborns across globe
1. Most aysmptomatic/mild symptoms
2.Most required no RS support
3. Good prognosis-0 deaths
4. 1 in 3 admitted from home
5. Median diagnosis D5; stay 10 days@EBNEO #neoEBM https://t.co/Q0GjmgUg2Y
— Abdul Razak (@DrAbdulRazak_MD) September 19, 2020
A history of herd immunity
20 Sep, 2020 | 21:32h | UTCA history of herd immunity – The Lancet
Comparison of published guidelines for management of coagulopathy and thrombosis in critically ill patients with COVID 19
20 Sep, 2020 | 21:30h | UTC
A national consensus management pathway for pediatric inflammatory multisystem syndrome temporally associated with COVID-19
20 Sep, 2020 | 21:31h | UTC
Uruguay is winning against Covid-19. This is how
20 Sep, 2020 | 21:27h | UTCUruguay is winning against covid-19. This is how – The BMJ
Commentary on Twitter
Latin America continues to suffer some of the worst tolls of covid-19 but somehow Uruguay has a lid on the pandemic. Its relatively small population made controlling transmission easier but never guaranteed success. @LukeStTaylor looks at how it's happened https://t.co/0k4PlTLQyo
— The BMJ (@bmj_latest) September 20, 2020
Editorial: Convalescent plasma for Covid-19
20 Sep, 2020 | 21:29h | UTCConvalescent plasma for covid-19 – The BMJ
Commentary on Twitter
Last month the US FDA authorised the emergency use of convalescent plasma for hospital patients with covid-19. What evidence underpinned the FDA’s controversial decision? And will the authorisation make it more difficult to recruit participants for RCTS? https://t.co/PMO13J2IOq
— The BMJ (@bmj_latest) September 19, 2020
Most homemade masks are doing a great job, even when we sneeze, study finds
20 Sep, 2020 | 21:22h | UTCMost homemade masks are doing a great job, even when we sneeze, study finds – MedicalXpress
Commentary on Twitter
Two layers of T-shirt cloth block droplets with >94% efficiency vs. medical masks, while being ~2x as breathable. Face coverings made from cotton allow washing and reusing, reducing environmental impact of disposable, non-biodegradable facemasks. 😷👕😷 https://t.co/kyqB4XoZMl
— peter kilmarx (@PeterKilmarx) August 26, 2020
Who gets a COVID vaccine first? Access plans are taking shape
20 Sep, 2020 | 21:24h | UTCWho gets a COVID vaccine first? Access plans are taking shape – Nature
Related: WHO Guidance: Allocation and prioritization of COVID-19 vaccination
Commentary on Twitter
Advisory groups around the world are working out plans for who should get priority access to a #covid19 vaccine: https://t.co/9g67rFJUrT pic.twitter.com/BLhAcKiVCK
— nature (@Nature) September 18, 2020
Hangover from alcohol boom could last long after pandemic ends
20 Sep, 2020 | 21:18h | UTCHangover From Alcohol Boom Could Last Long After Pandemic Ends – NPR
Commentary on Twitter
The alcohol industry has thrived during the #pandemic. But alcohol-related illnesses kill 88,000+ Americans every year—and the skyrocketing sales suggest a worrying reliance on alcohol to ease a stressful situation. https://t.co/8GIbAi9dM7
— Global Health NOW (@ghn_news) September 20, 2020
Systematic review: Therapies for clinically localized prostate cancer
20 Sep, 2020 | 21:15h | UTCTherapies for Clinically Localized Prostate Cancer – Agency for Healthcare Research and Quality
Final report: Therapies for Clinically Localized Prostate Cancer AND Evidence Summary
Perspective: How we survive the winter
20 Sep, 2020 | 21:21h | UTCHow We Survive the Winter – The Atlantic
CDC Guidance: Indicators for dynamic school decision-making
18 Sep, 2020 | 09:45h | UTCIndicators for Dynamic School Decision-Making – Centers for Disease Control and Prevention
Commentary on Twitter
CDC releases new epi indicators and thresholds for risk of introduction and transmission of COVID-19 in schools https://t.co/jGQUV149Wt pic.twitter.com/xNmA7iUbaF
— Caitlin Rivers (@cmyeaton) September 16, 2020
The Lancet NCDI Poverty Commission: bridging a gap in universal health coverage for the poorest billion
20 Sep, 2020 | 21:16h | UTC
Commentary on Twitter
Non-communicable diseases & injuries (NCDI) cause more death & disability at every age among the world’s poorest billion than in wealthy countries— new @ncdipoverty Commission provides cost-effective & equitable interventions to address #NCDIPoverty https://t.co/MPunOR7fws pic.twitter.com/IrGj2obZXx
— The Lancet (@TheLancet) September 14, 2020
Transmission of SARS-CoV-2: A review of viral, host, and environmental factors
18 Sep, 2020 | 09:43h | UTC
[Abstract Only] Survival with Olaparib in metastatic castration-resistant prostate cancer
20 Sep, 2020 | 21:13h | UTC
Commentary on Twitter
The PROfound trial showed that olaparib prolonged imaging-based progression-free survival among patients whose tumors contained defects in the BRCA1, BRCA2, or ATM. With longer follow-up, the trial now shows that olaparib prolonged overall survival in these patients. #ESMO20
— NEJM (@NEJM) September 20, 2020